[144] iRhythm Technologies, Inc SEC Filing
Form 144 filed for iRhythm Technologies (IRTC) shows an insider intends to sell a small block of common stock through Morgan Stanley Smith Barney on NASDAQ. The notice specifies 226 shares with an aggregate market value of $35,918.18, acquired under the company Employee Stock Purchase Plan on 11/30/2023 and paid for in cash. The filer previously sold 696 shares on 06/02/2025 for $97,586.16. With 32,127,763 shares outstanding reported on the form, the planned sale represents approximately 0.0007% of the outstanding shares, indicating the transaction is immaterial to total equity. The filer certifies there is no undisclosed material adverse information and includes standard Rule 10b5-1 language if applicable.
Modulo 144 presentato per iRhythm Technologies (IRTC) indica che un insider intende vendere un piccolo blocco di azioni ordinarie tramite Morgan Stanley Smith Barney sul NASDAQ. L'avviso specifica 226 azioni con un valore di mercato complessivo di $35,918.18, acquisite nell'ambito del Piano di Acquisto Azionario per Dipendenti il 11/30/2023 e pagate in contanti. Il dichiarante ha precedentemente venduto 696 azioni il 06/02/2025 per $97,586.16. Con 32,127,763 azioni in circolazione indicate nel modulo, la vendita pianificata rappresenta circa 0.0007% delle azioni in circolazione, il che rende la transazione irrilevante rispetto al patrimonio complessivo. Il dichiarante certifica l'assenza di informazioni avverse materiali non divulgate e include, se applicabile, il linguaggio standard previsto dalla Regola 10b5-1.
Formulario 144 presentado para iRhythm Technologies (IRTC) muestra que un insider tiene la intenci贸n de vender un peque帽o bloque de acciones ordinarias a trav茅s de Morgan Stanley Smith Barney en NASDAQ. La notificaci贸n especifica 226 acciones con un valor de mercado agregado de $35,918.18, adquiridas bajo el Plan de Compra de Acciones para Empleados el 11/30/2023 y pagadas en efectivo. El declarante vendi贸 anteriormente 696 acciones el 06/02/2025 por $97,586.16. Con 32,127,763 acciones en circulaci贸n reportadas en el formulario, la venta prevista representa aproximadamente 0.0007% de las acciones en circulaci贸n, lo que indica que la transacci贸n es insignificante para el capital total. El declarante certifica que no existe informaci贸n adversa material no divulgada e incluye, si procede, el lenguaje est谩ndar de la Regla 10b5-1.
iRhythm Technologies(IRTC)鞐� 雽�頃� Form 144 鞝滌稖鞚� 雮措秬鞛愱皜 Morgan Stanley Smith Barney毳� 韱淀暣 NASDAQ鞐愳劀 靻岆焿鞚� 氤错喌欤茧ゼ 毵る弰頃� 鞚橃偓臧� 鞛堨潓鞚� 氤挫棳欷嶋媹雼�. 韱奠靹滊姅 226欤�鞕赌 齑� 鞁滌灔 臧�旃� $35,918.18毳� 氇呾嫓頃橂┌, 鞚措姅 11/30/2023鞐� 歆侅洂 欤检嫕 毵れ瀰 瓿勴殟(Employee Stock Purchase Plan)鞚� 韱淀暣 旆摑頃橃棳 順勱笀鞙茧 瓴办牅霅� 瓴冹瀰雼堧嫟. 鞝滌稖鞚胳潃 鞚挫爠鞐� 06/02/2025鞐� 696欤�毳� $97,586.16鞐� 毵る弰頃� 氚� 鞛堨姷雼堧嫟. 鞏戩嫕鞐� 氤搓碃霅� 32,127,763欤检潣 氚滍枆 欤检嫕 靾� 旮办鞙茧 鞚措矆 瓿勴殟霅� 毵る弰電� 氚滍枆 欤检嫕鞚� 鞎� 0.0007%鞐� 頃措嫻頃橃棳 齑� 鞛愲掣鞐� 氙鸽頃� 瓯半灅鞛勳潉 雮橅儉雰呺媹雼�. 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃橂┌, 頃措嫻霅橂姅 瓴届毎 攴滌箼 10b5-1鞚� 響滌 氍戈惮毳� 韽暔頃╇媹雼�.
Formulaire 144 d茅pos茅 pour iRhythm Technologies (IRTC) indique qu'un initi茅 a l'intention de vendre un petit bloc d'actions ordinaires via Morgan Stanley Smith Barney sur le NASDAQ. L'avis pr茅cise 226 actions pour une valeur marchande totale de $35,918.18, acquises dans le cadre du Plan d'Achat d'Actions des Employ茅s le 11/30/2023 et pay茅es en esp猫ces. Le d茅clarant a pr茅c茅demment vendu 696 actions le 06/02/2025 pour $97,586.16. Avec 32,127,763 actions en circulation d茅clar茅es sur le formulaire, la vente pr茅vue repr茅sente environ 0.0007% des actions en circulation, ce qui indique que la transaction est n茅gligeable par rapport aux capitaux propres totaux. Le d茅clarant certifie qu'il n'existe aucune information n茅gative mat茅rielle non divulgu茅e et inclut, le cas 茅ch茅ant, la formulation standard de la r猫gle 10b5-1.
Formular 144 蹿眉谤 iRhythm Technologies (IRTC) zeigt, dass ein Insider beabsichtigt, einen kleinen Block von Stammaktien 眉ber Morgan Stanley Smith Barney an der NASDAQ zu verkaufen. Die Mitteilung nennt 226 Aktien mit einem gesamten Marktwert von $35,918.18, erworben im Rahmen des Employee Stock Purchase Plan am 11/30/2023 und bar bezahlt. Der Einreicher hat zuvor 696 Aktien am 06/02/2025 蹿眉谤 $97,586.16 verkauft. Bei 32,127,763 im Formular ausgewiesenen ausstehenden Aktien entspricht der geplante Verkauf etwa 0.0007% der ausstehenden Aktien, was die Transaktion als unerheblich 蹿眉谤 das Gesamtkapital erscheinen l盲sst. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen, und f眉gt gegebenenfalls die Standardformulierung der Regel 10b5-1 bei.
- None.
- None.
Insights
TL;DR Insider plans to sell a very small stake鈥攖ransaction size is immaterial relative to shares outstanding.
The Form 144 discloses a proposed sale of 226 common shares valued at $35,918.18 through Morgan Stanley Smith Barney on NASDAQ. The shares were acquired via the Employee Stock Purchase Plan on 11/30/2023. A prior sale of 696 shares on 06/02/2025 generated $97,586.16. Relative to the 32,127,763 shares outstanding shown on the form, the current notice represents about 0.0007% of outstanding shares, which is unlikely to alter market perception or company valuation. Disclosure appears routine and consistent with insider liquidity under an ESPP.
TL;DR Filing reflects routine insider liquidity; no governance red flags evident from disclosed facts.
The notice includes required attestations that no undisclosed material adverse information exists and references possible Rule 10b5-1 instructions. The transaction size and prior recent sale suggest opportunistic, small-scale disposition of shares acquired through an ESPP rather than a vote of no confidence by management. All material items in the form are disclosed: acquisition method, payment type, broker, amounts, and past three-month sales, meeting regulatory transparency expectations.
Modulo 144 presentato per iRhythm Technologies (IRTC) indica che un insider intende vendere un piccolo blocco di azioni ordinarie tramite Morgan Stanley Smith Barney sul NASDAQ. L'avviso specifica 226 azioni con un valore di mercato complessivo di $35,918.18, acquisite nell'ambito del Piano di Acquisto Azionario per Dipendenti il 11/30/2023 e pagate in contanti. Il dichiarante ha precedentemente venduto 696 azioni il 06/02/2025 per $97,586.16. Con 32,127,763 azioni in circolazione indicate nel modulo, la vendita pianificata rappresenta circa 0.0007% delle azioni in circolazione, il che rende la transazione irrilevante rispetto al patrimonio complessivo. Il dichiarante certifica l'assenza di informazioni avverse materiali non divulgate e include, se applicabile, il linguaggio standard previsto dalla Regola 10b5-1.
Formulario 144 presentado para iRhythm Technologies (IRTC) muestra que un insider tiene la intenci贸n de vender un peque帽o bloque de acciones ordinarias a trav茅s de Morgan Stanley Smith Barney en NASDAQ. La notificaci贸n especifica 226 acciones con un valor de mercado agregado de $35,918.18, adquiridas bajo el Plan de Compra de Acciones para Empleados el 11/30/2023 y pagadas en efectivo. El declarante vendi贸 anteriormente 696 acciones el 06/02/2025 por $97,586.16. Con 32,127,763 acciones en circulaci贸n reportadas en el formulario, la venta prevista representa aproximadamente 0.0007% de las acciones en circulaci贸n, lo que indica que la transacci贸n es insignificante para el capital total. El declarante certifica que no existe informaci贸n adversa material no divulgada e incluye, si procede, el lenguaje est谩ndar de la Regla 10b5-1.
iRhythm Technologies(IRTC)鞐� 雽�頃� Form 144 鞝滌稖鞚� 雮措秬鞛愱皜 Morgan Stanley Smith Barney毳� 韱淀暣 NASDAQ鞐愳劀 靻岆焿鞚� 氤错喌欤茧ゼ 毵る弰頃� 鞚橃偓臧� 鞛堨潓鞚� 氤挫棳欷嶋媹雼�. 韱奠靹滊姅 226欤�鞕赌 齑� 鞁滌灔 臧�旃� $35,918.18毳� 氇呾嫓頃橂┌, 鞚措姅 11/30/2023鞐� 歆侅洂 欤检嫕 毵れ瀰 瓿勴殟(Employee Stock Purchase Plan)鞚� 韱淀暣 旆摑頃橃棳 順勱笀鞙茧 瓴办牅霅� 瓴冹瀰雼堧嫟. 鞝滌稖鞚胳潃 鞚挫爠鞐� 06/02/2025鞐� 696欤�毳� $97,586.16鞐� 毵る弰頃� 氚� 鞛堨姷雼堧嫟. 鞏戩嫕鞐� 氤搓碃霅� 32,127,763欤检潣 氚滍枆 欤检嫕 靾� 旮办鞙茧 鞚措矆 瓿勴殟霅� 毵る弰電� 氚滍枆 欤检嫕鞚� 鞎� 0.0007%鞐� 頃措嫻頃橃棳 齑� 鞛愲掣鞐� 氙鸽頃� 瓯半灅鞛勳潉 雮橅儉雰呺媹雼�. 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃橂┌, 頃措嫻霅橂姅 瓴届毎 攴滌箼 10b5-1鞚� 響滌 氍戈惮毳� 韽暔頃╇媹雼�.
Formulaire 144 d茅pos茅 pour iRhythm Technologies (IRTC) indique qu'un initi茅 a l'intention de vendre un petit bloc d'actions ordinaires via Morgan Stanley Smith Barney sur le NASDAQ. L'avis pr茅cise 226 actions pour une valeur marchande totale de $35,918.18, acquises dans le cadre du Plan d'Achat d'Actions des Employ茅s le 11/30/2023 et pay茅es en esp猫ces. Le d茅clarant a pr茅c茅demment vendu 696 actions le 06/02/2025 pour $97,586.16. Avec 32,127,763 actions en circulation d茅clar茅es sur le formulaire, la vente pr茅vue repr茅sente environ 0.0007% des actions en circulation, ce qui indique que la transaction est n茅gligeable par rapport aux capitaux propres totaux. Le d茅clarant certifie qu'il n'existe aucune information n茅gative mat茅rielle non divulgu茅e et inclut, le cas 茅ch茅ant, la formulation standard de la r猫gle 10b5-1.
Formular 144 蹿眉谤 iRhythm Technologies (IRTC) zeigt, dass ein Insider beabsichtigt, einen kleinen Block von Stammaktien 眉ber Morgan Stanley Smith Barney an der NASDAQ zu verkaufen. Die Mitteilung nennt 226 Aktien mit einem gesamten Marktwert von $35,918.18, erworben im Rahmen des Employee Stock Purchase Plan am 11/30/2023 und bar bezahlt. Der Einreicher hat zuvor 696 Aktien am 06/02/2025 蹿眉谤 $97,586.16 verkauft. Bei 32,127,763 im Formular ausgewiesenen ausstehenden Aktien entspricht der geplante Verkauf etwa 0.0007% der ausstehenden Aktien, was die Transaktion als unerheblich 蹿眉谤 das Gesamtkapital erscheinen l盲sst. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen, und f眉gt gegebenenfalls die Standardformulierung der Regel 10b5-1 bei.
FAQ
What does the IRTC Form 144 disclose about the planned sale?
Who is the seller listed on the IRTC Form 144?
When were the shares being sold originally acquired?
Has the filer sold other IRTC shares recently?
How material is the planned sale relative to IRTC's outstanding shares?
